Fetuin-A 742 (C/T) and 766 (C/G) polymorphic sites are associated with increased risk of myocardial infarction in older patients (≥40 years of age)

Coker‑Gurkan,Ajda; Coskun,Deniz; Arisan,Elif  Damla; Obakan,Pinar; Soylu,Özer; Unsal,Narcin  Palavan

doi:10.3892/mmr.2015.3521

July-2015 Volume 12 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2015 Volume 12 Issue 1

Full Size Image

Article

Fetuin-A 742 (C/T) and 766 (C/G) polymorphic sites are associated with increased risk of myocardial infarction in older patients (≥40 years of age)

Authors:
- Ajda Coker‑Gurkan
- Deniz Coskun
- Elif Damla Arisan
- Pinar Obakan
- Özer Soylu
- Narcin Palavan Unsal
View Affiliations / Copyright

Affiliations: Department of Molecular Biology and Genetics, Istanbul Kultur University, Atakoy Campus, Istanbul 34156, Turkey, Heart and Vessel Surgery Department, Medical Park Hospital, Istanbul 34732, Turkey
Pages: 1356-1362
|
Published online on: March 20, 2015

https://doi.org/10.3892/mmr.2015.3521
Expand metrics +

Abstract

Inflammation and genetics have key roles in the pathogenesis of atherosclerosis, and the etiology of myocardial infarction (MI). Recent studies have indicated that lower serum levels of fetuin‑A may accelerate the vascular mineralization process, which leads to pathophysiological conditions, such as coronary heart disease and chronic renal failure. The aim of the present study was to evaluate the association between specific fetuin‑A polymorphisms (742 and 766) that are associated with circulating serum levels, and MI cases. The study consisted of 292 participants; 146 healthy control subjects and 146 patients with MI. The patient group was divided into two subgroups: 56 MI≤40 years and 90 MI≥40 years. The genotype distribution of fetuin 742 (C/T) and fetuin 766 (C/G) were determined by restriction enzyme digestion of polymerase chain reaction products. A significant difference was determined between the patients with MI and the control subjects with regards to fetuin‑A 742 C/T gene polymorphism (P=0.028), regardless of age. Genotype distributions of fetuin‑A 742 (C/G, P=0.004) and 766 (C/T, P=0.017) were statistically different in the older patients with MI (MI≥40 years old), as compared with the healthy controls; however, there were no significant differences between the younger patients with MI and the controls, with regards to fetuin‑A 742 C/T (P=0.519) and 766 C/G (P=0.653) gene polymorphisms. In addition, an association was observed between the presence of fetuin‑A 742 T and 766 G alleles, and MI cases. The present study demonstrates that fetuin‑A 742 (C/T) and 766 (C/G) genotypes may be risk factors for MI in patients older than 40 years of age.

View Figures

View References

1	Pouleur AC, Barkoudah E, Uno H, et al: Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 122:597–602. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wang H and Eitzman DT: Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis. 229:18–22. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ross R: Atherosclerosis is an inflammatory disease. Am Heart J. 138:419–420. 1999. View Article : Google Scholar
4	Hong C, Zhu F, Du D, Pilgram TK, Sicard GA and Bae KT: Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis. 183:169–174. 2005. View Article : Google Scholar : PubMed/NCBI
5	McGeachie M, Ramoni RL, Mychaleckyj JC, et al: Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation. 120:2448–2454. 2009. View Article : Google Scholar : PubMed/NCBI
6	Westenfeld R, Schäfer C, Smeets R, et al: Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 22:1537–1546. 2007. View Article : Google Scholar : PubMed/NCBI
7	Anderson L and Anderson NG: High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA. 74:5421–5425. 1977. View Article : Google Scholar : PubMed/NCBI
8	Lee CC, Bowman BH and Yang FM: Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript. Proc Natl Acad Sci USA. 84:4403–4407. 1987. View Article : Google Scholar : PubMed/NCBI
9	Jahnen-Dechent W, Schinke T, Trindl A, et al: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem. 272:31496–31503. 1997. View Article : Google Scholar
10	Auberger P, Falquerho L, Contreres JO, et al: Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification and anti-mitogenic activity. Cell. 58:631–640. 1989. View Article : Google Scholar : PubMed/NCBI
11	Dahlman I, Eriksson P, Kaaman M, et al: alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia. 47:1974–1979. 2004. View Article : Google Scholar : PubMed/NCBI
12	Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP and Humbert G: Serum concentration of human alpha 2 HS glyco-protein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest. 64:1118–1129. 1979. View Article : Google Scholar : PubMed/NCBI
13	Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 112:357–366. 2003. View Article : Google Scholar : PubMed/NCBI
14	Rizzu P and Baldini A: Three members of the human cystatin gene superfamily, AHSG, HRG and KNG, map within one megabase of genomic DNA at 3q27. Cytogenet Cell Genet. 70:26–28. 1995. View Article : Google Scholar
15	Osawa M, Umetsu K, Sato M, et al: Structure of the gene encoding human alpha 2-HS glycoprotein (AHSG). Gene. 196:121–125. 1997. View Article : Google Scholar : PubMed/NCBI
16	Osawa M, Yuasa I, Kitano T, et al: Haplotype analysis of the human alpha2-HS glycoprotein (fetuin) gene. Ann Hum Genet. 65:27–34. 2001. View Article : Google Scholar : PubMed/NCBI
17	Stenvinkel P, Pecoits-Filho R, Lindholm B and DialGene C: Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial. 18:322–330. 2005. View Article : Google Scholar : PubMed/NCBI
18	Weikert C, Stefan N, Schulze MB, et al: Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 118:2555–2562. 2008. View Article : Google Scholar : PubMed/NCBI
19	Mehrotra R, Westenfeld R, Christenson P, et al: Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 67:1070–1077. 2005. View Article : Google Scholar : PubMed/NCBI
20	Lim P, Collet JP, Moutereau S, et al: Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem. 53:1835–1840. 2007. View Article : Google Scholar : PubMed/NCBI
21	Fisher E, Stefan N, Saar K, et al: Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2:607–613. 2009. View Article : Google Scholar : PubMed/NCBI
22	Fried LP, Borhani NO, Enright P, et al: The cardiovascular health study: design and rationale. Ann Epidemiol. 1:263–276. 1991. View Article : Google Scholar : PubMed/NCBI
23	Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
24	Chen W: Rapid isolation of DNA from human peripheral blood. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 14:141–142. 1992.In Chinese. PubMed/NCBI
25	Murray CJ and Lopez AD: Evidence-based health policy-lessons from the global burden of disease study. Science. 274:740–743. 1996. View Article : Google Scholar : PubMed/NCBI
26	Yusuf S, Reddy S, Ounpuu S and Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation. 104:2746–2753. 2001. View Article : Google Scholar : PubMed/NCBI
27	Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 97:1837–1847. 1998. View Article : Google Scholar : PubMed/NCBI
28	Maseri A and Fuster V: Is there a vulnerable plaque? Circulation. 107:2068–2071. 2003. View Article : Google Scholar : PubMed/NCBI
29	Holmes DR Jr, Hartzler GO, Smith HC and Fuster V: Coronary artery thrombosis in patients with unstable angina. Br Heart J. 45:411–416. 1981. View Article : Google Scholar : PubMed/NCBI
30	Mandelkorn JB, Wolf NM, Singh S, et al: Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol. 52:1–6. 1983. View Article : Google Scholar : PubMed/NCBI
31	Ambrose JA, Winters SL, Arora RR, et al: Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol. 6:1233–1238. 1985. View Article : Google Scholar : PubMed/NCBI
32	Doherty TM, Detrano RC, Mautner SL, Mautner GC and Shavelle RM: Coronary calcium: the good, the bad and the uncertain. Am Heart J. 137:806–814. 1999. View Article : Google Scholar : PubMed/NCBI
33	Shemesh J, Stroh CI, Tenenbaum A, et al: Comparison of coronary calcium in stable angina pectoris and in first acute myocardial infarction utilizing double helical computerized tomography. Am J Cardiol. 81:271–275. 1998. View Article : Google Scholar : PubMed/NCBI
34	Raggi P, Cooil B, Shaw LJ, et al: Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol. 92:827–829. 2003. View Article : Google Scholar : PubMed/NCBI
35	Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A and Witteman JC: Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The rotterdam coronary calcification study. Eur Heart J. 23:1596–1603. 2002. View Article : Google Scholar : PubMed/NCBI
36	Schinke T, Amendt C, Trindl A, Pöpschke O, Müller-Esterl W and Jahnen-Dechent W: The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 271:20789–20796. 1996. View Article : Google Scholar : PubMed/NCBI
37	Merx MW, Schäfer C, Westenfeld R, et al: Myocardial stiffness, cardiac remodeling and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol. 16:3357–3364. 2005. View Article : Google Scholar : PubMed/NCBI
38	Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 29:853–857. 2006. View Article : Google Scholar : PubMed/NCBI
39	Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 361:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
40	Kaden JJ, Reinöhl JO, Blesch B, et al: Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int J Mol Med. 20:193–197. 2007.PubMed/NCBI
41	Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M and Whooley MA: Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 115:2533–2539. 2007. View Article : Google Scholar : PubMed/NCBI
42	Afsar CU, Uzun H, Yurdakul S, et al: Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome. Clin Invest Med. 35:E206–E215. 2012.PubMed/NCBI